These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 184948

  • 1. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Costlow ME, Buschow RA, McGuire WL.
    Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptors in androgen-induced breast tumor regression.
    Zava DT, McGuire WL.
    Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
    [Abstract] [Full Text] [Related]

  • 3. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
    Costlow ME, Buschow RA, McGuire WL.
    Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
    [Abstract] [Full Text] [Related]

  • 4. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [Abstract] [Full Text] [Related]

  • 5. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
    [Abstract] [Full Text] [Related]

  • 6. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A, Trujillo JE, Pearson OH.
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [Abstract] [Full Text] [Related]

  • 7. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP, Noonan JJ.
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [Abstract] [Full Text] [Related]

  • 8. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS, Bradley CJ, Marshall S, Campbell GA, Meites J.
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [Abstract] [Full Text] [Related]

  • 9. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA, Asselin J, Caron MG, Raynaud JP, Labrie F.
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML, Levy J, Rosen JM.
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [Abstract] [Full Text] [Related]

  • 11. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD, Hilf R, Senior AE.
    Cancer Biochem Biophys; 1979 May; 3(3):117-21. PubMed ID: 121922
    [Abstract] [Full Text] [Related]

  • 12. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL, Diamond EJ, Koprak S, Hollander VP.
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [Abstract] [Full Text] [Related]

  • 13. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM, Friesen HG.
    Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
    [Abstract] [Full Text] [Related]

  • 14. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL, Katzenellenbogen BS.
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [Abstract] [Full Text] [Related]

  • 15. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS, Sasaki GH, Leung JS.
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [Abstract] [Full Text] [Related]

  • 16. Characterization of androgen receptors in 7,12-dimethylbenz(a)-anthracene-induced and transplantable rat mammary tumors.
    Ip MM, Milholland RJ, Kim U, Rosen F.
    Cancer Res; 1978 Sep; 38(9):2879-85. PubMed ID: 98230
    [No Abstract] [Full Text] [Related]

  • 17. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P, Mélançon R, Djiane J, Kelly PA.
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [Abstract] [Full Text] [Related]

  • 18. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [Abstract] [Full Text] [Related]

  • 19. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL, Hilf R.
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic localization of prolactin receptors in 7,12-dimethylbnez[a]anthracene-induced rat mammary carcinoma.
    Costlow ME, McGuire WL.
    J Natl Cancer Inst; 1977 Apr; 58(4):1173-5. PubMed ID: 191627
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.